For citation: Krivonozhkina P.S., Miroshnikova V.V., Poplavskaya A.A., Shorina M.N. Pathogenetic targets of chronic migraine: rationale for the use of botulinum toxin type A and anti-CGRP therapy. Clinical review for general practice. 2026; 7 (3): 32–37 (In Russ.). DOI: 10.47407/kr2026.7.3.00790
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
